AmalI Khalil | Digital Transformation | Best Researcher Award

Posted on by Business Strategy

Prof. AmalI Khalil | Digital Transformation | Best Researcher Award

Prof. AmalI Khalil, King Saud bin Abdulaziz University of Health Sciences, Saudi Arabia.

Prof. Amal Khalil is a highly respected Egyptian academic and healthcare educator specializing in psychiatric and mental health nursing. Born on March 24, 1970, in Egypt, she currently serves as a professor at the College of Nursing, King Saud Bin Abdulaziz University for Health Sciences (KSAU-HS) in Jeddah, Saudi Arabia. Fluent in Arabic and English, Prof. Khalil is known for her dedication to academic leadership, research advancement, and faculty development. She plays a vital role in student advising and counseling while promoting interdisciplinary learning environments. Her warm and inclusive approach helps shape resilient and compassionate future nurses. With over 30 years of professional experience, she has contributed significantly to curriculum innovation, national accreditation, and clinical training excellence. Prof. Khalil’s proactive engagement in institutional growth and capacity-building initiatives reflects her core values of integrity, empathy, and lifelong learning. She continues to inspire both students and faculty with her visionary approach to healthcare education.

👩‍⚕️ Profile

Orcid

📚 Education 

Prof. Amal Khalil holds a distinguished academic record that underscores her lifelong commitment to psychiatric and mental health nursing. She began her journey with a Bachelor of Science in Nursing from Tanta University in 1991. Her passion for mental health led her to pursue a Master’s degree (1999) and a Doctorate (2004) in Psychiatric and Mental Health Nursing from Menoufia University, Egypt. She achieved academic milestones with progressive faculty promotions—Assistant Professor in 2009 at KSAU-HS, Associate Professor in 2013, and ultimately becoming a full Professor in 2020. Complementing her formal degrees, Prof. Khalil holds a Diploma in Psychology, is a Certified Trainer of Trainers (TOT), and earned a mindfulness meditation certification from Alison Center in the USA. These qualifications empower her to deliver holistic and modern instruction tailored to current healthcare demands. Her interdisciplinary background uniquely positions her to blend psychological well-being with evidence-based nursing education in diverse academic settings.

💼 Experience 

Prof. Amal Khalil’s professional journey spans over three decades of educational, clinical, and administrative excellence. At KSAU-HS, she plays a leading role in developing nursing curricula, overseeing academic counseling, and conducting research-driven faculty development. Her teaching portfolio spans multiple disciplines including radiological sciences and psychiatric nursing. She has led numerous workshops such as “Mental Health First Aid,” “SWOT Analysis for Nursing Professionals,” and “Communication Etiquette in the Workplace.” In recognition of her leadership, she has been entrusted with roles like co-chair of the Advising and Counselling Unit, member of the accreditation committee, and contributor to career guidance programs. She bridges academic theory with real-world application, supporting both undergraduates and healthcare professionals in skill development. Her impactful teaching and mentorship have significantly improved student satisfaction, professional readiness, and cross-functional faculty collaboration. Through continuous innovation, Prof. Khalil ensures that KSAU-HS remains a hub for ethical and future-ready healthcare education in the region.

🔬 Research Interests 

Prof. Amal Khalil’s research interests align with her clinical and academic expertise in psychiatric and mental health nursing. Her primary focus areas include mindfulness practices in education, mental health literacy among students, and resilience-building interventions in high-stress healthcare environments. She also investigates the pedagogical impact of personal SWOT analysis and mental health first aid training for nursing students and faculty. Additionally, she explores innovative methods in academic writing, including problem statement development and hypothesis formulation. Prof. Khalil actively contributes to multidisciplinary research and has led studies that integrate psychological wellness with academic performance in nursing programs. She frequently collaborates on curriculum-based research workshops aimed at elevating academic rigor and reflective practice. Her research not only informs her teaching but also fosters institutional growth and professional development for both faculty and students. Prof. Khalil’s scholarly vision promotes a compassionate, research-informed approach to education, mental wellness, and patient-centered healthcare delivery.

🏆 Awards 

Prof. Amal Khalil has been honored with numerous accolades that underscore her exceptional contributions to nursing education, faculty development, and research innovation. In 2025 alone, she received multiple Certificates of Appreciation—from serving as a co-chair of the Advising and Counselling Unit to leading faculty workshops on communication and mindfulness. Her achievements in academic accreditation earned high recognition during the NCAAA process. She was also awarded a 1st-place monetary prize at the 2024 CONJ Research Day. Between 2023 and 2024, she led and spoke at over a dozen workshops and faculty enhancement sessions, ranging from research methodology to career guidance. Earlier, she received trophies and awards at HPC 2017, 2018, and 2019 for poster presentations and public health contributions. Her recognition extends across disciplines, reflecting her influence as both a healthcare educator and scholar. Prof. Khalil’s consistent excellence, institutional service, and commitment to learning position her as a role model in academic nursing.

📖 Publications

Effectiveness of Mindfulness Meditation Among Nursing Students

SWOT-Driven Mindset in Nursing Education

Impact of Mental Health First Aid Training

Bruno LAVIOLLE | Produits de santé | Best Researcher Award

Posted on by Business Strategy

Prof. Bruno LAVIOLLE  –  Produits de santé(Health products) – Best Researcher Award

Alignment with Award Category

Professor Laviolle’s sustained research excellence, commitment to teaching and mentoring, and innovative contributions to clinical pharmacology make him exceptionally well-suited for the Best Researcher Award or a category recognizing Excellence in Translational Research or Methodological Innovation.

CHU de Rennes | France

Profile
scopus

🎓Early Academic Pursuits 

Education and Training

Born with a passion for science and healthcare, Bruno LAVIOLLE, MD, PhD (N° d’ordre : 35/5922; N° RPPS : 10002677705) embarked on a rich and rigorous academic journey in the biomedical sciences. His academic foundations were laid with a Bachelor in Science during 1997-98, encompassing Biostatistics, Informatics and Modelling at Nantes University, alongside Methods in Clinical Epidemiology and Clinical Research, and Cellular Pharmacology, Pharmacogenetics, and Pharmacokinetics at Rennes 1 University. Driven by a commitment to clinical excellence, he obtained a Master’s in Human Science with a specialization in Fundamental and Clinical Pharmacology from Paris 11 University in 2002. In the same year, he also earned a Certificate in Public Health from Rennes 1 University, setting the stage for a multidimensional understanding of medicine and pharmacology. He achieved his Medical Doctor degree in 2003, followed by certification in Clinical Pharmacology and Therapeutic Research in 2004. His thirst for research culminated in a PhD in 2011 and an Accreditation to Supervise Doctoral Research in 2013, both from Rennes 1 University.

💼Professional Endeavors 

Academic Positions

Professor Bruno Laviolle currently holds multiple influential positions. He serves as a Professor of Clinical Pharmacology at Rennes 1 University and Rennes University Hospital, where he is also Director of the Clinical Investigation Centre, Inserm 1414, located at Hôpital de Pontchaillou in Rennes, France. His dual affiliation with Inserm UMR_S 1085 (Irset) and the Clinical Investigation Centre (Inserm 1414) underscores his central role in bridging translational research and clinical pharmacology. Through these institutions, he plays a crucial role in developing and managing pharmacological studies, advancing medical therapies, and training future experts in the field.

📚Contributions and Research Focus on Produits de santé(Health products)

Bruno Laviolle’s research lies at the intersection of clinical pharmacology, cardiovascular pharmacology, and clinical investigation methodologies. His work is characterized by robust biostatistical modeling, rigorous methodologies for clinical trials, and deep expertise in pharmacokinetics and pharmacodynamics. He is especially recognized for his efforts in clinical investigations in cardiovascular pharmacology, an area where his contributions have had meaningful impacts on patient care and drug safety. As the Director of Inserm 1414, he spearheads major clinical trials and translational research projects. His commitment to scientific excellence extends into education, where he leads the Master’s Course of Clinical Research at Rennes University. Additionally, he is actively involved in training medical and graduate students in clinical trial methodology, pharmacological modeling, and biostatistics, equipping the next generation of healthcare professionals with vital research competencies.

🏆Accolades and Recognition 

Professor Laviolle’s remarkable career is supported by his membership in esteemed organizations. He is a valued member of the French Society of Pharmacology and Therapeutics, the European Association for Clinical Pharmacology, and the American College of Clinical Pharmacology, where he serves on the education committee. Furthermore, his membership in the French Association of Medical School Teachers of Pharmacology highlights his respected position in the academic community. These affiliations reflect the high regard in which his peers hold his clinical, academic, and research contributions. His dedication to education and public health has earned him numerous accolades and sustained recognition in both national and international medical communities.

🌍 Impact and Influence 

Community Impact

The impact of Bruno Laviolle’s work reverberates through both clinical practice and academic circles. His influence is evident in the curriculum he has helped shape for medical students and Master’s level scholars at Rennes University, particularly in critical reading of scientific publications, clinical biostatistics, and pharmacological modeling. Through his leadership at Inserm 1414, he has directly influenced the design and implementation of critical drug trials and research protocols in France and beyond. His dual expertise in clinical medicine and research methodology has positioned him as a key figure in fostering evidence-based clinical practices, particularly in cardiovascular pharmacology and public health intervention trials.

🔮Legacy and Future Contributions 

As a dedicated academic and clinician, Bruno Laviolle has built a legacy of scientific rigor, mentorship, and interdisciplinary innovation. His role in developing comprehensive training programs in clinical pharmacology will continue to influence future generations of researchers and physicians. His ongoing involvement in methodological education and clinical investigation ensures that his impact will not only persist but grow. Looking forward, Bruno Laviolle remains at the frontier of pharmacological research, aiming to deepen the integration of data-driven approaches in clinical medicine, enhance patient outcomes, and refine the tools of modern pharmacology. His dedication to mentoring doctoral students and contributing to global scientific dialogue guarantees a lasting footprint in the field.

Conclusion

Bruno Laviolle, MD, PhD, exemplifies the ideals of a physician-scientist: one who bridges theory with practice, research with application, and knowledge with teaching. From his early academic strides through a rich tapestry of multidisciplinary education, to his current role as a Professor of Clinical Pharmacology and Director of Inserm 1414, his career is marked by excellence, innovation, and influence. Whether through his leadership in clinical investigation, his involvement in international pharmacological associations, or his passion for education, Professor Laviolle has significantly shaped the modern landscape of clinical pharmacology. His work not only enhances the effectiveness and safety of therapeutic interventions but also inspires a new generation of clinical researchers and pharmacologists in France and around the world.

📚Publications

Trends of Publication of Negative Trials Over Time

 Authors: B., Laviolle, Bruno, C., Locher, Clara, J.S., Allain, Jean Sebastien, … É., Bellissant, Éric, F., Naudet, Florian

Journals: Clinical Pharmacology and Therapeutics

Day-to-day dynamics of fetal heart rate variability to detect chorioamnionitis in preterm premature rupture of membranes

Authors: A., Taoum, Aline, G., Carrault, Guy, C., Tesson, Caroline, … B., Laviolle, Bruno, L., Lassel, Linda

Journals: PLoS ONE

Association between humoral serological markers levels and risk of SARS-CoV-2 infection after the primary COVID-19 vaccine course among ANRS0001S COV-POPART cohort participants

Authors: M., Chalouni, Mathieu, P., Loubet, Paul, E., Lhomme, Edouard, … O., Launay, Odile, L., Wittkop, Linda

Journals: BMC Infectious Disease

Development and validation of a community acquired sepsis-worsening score in the adult emergency department: a prospective cohort: the CASC score

Authors: F., Saget, François, A., Maamar, Adel, M., Esvan, Maxime, … N., Peschanski, N., B., Laviolle, Bruno

Journals: BMC Emergency Medicine

Vladimir Badmaev | Pharma | Industry Impact Award

Posted on by Business Strategy

Dr. Vladimir Badmaev  –  Pharma  –  Industry Impact Award

Alignment with Award Category

Dr. Badmaev’s research and innovations align seamlessly with the Industry Impact Award criteria. His pioneering work in natural pharma and smart drug development, along with his numerous patents and product contributions, make him a highly deserving candidate.

American Medical Holdings Inc. | United States

Profile

Orcid

Scopus

🎓Early Academic Pursuits 

Education and Training

Vladimir Badmaev, MD, PhD, embarked on his academic journey at the Medical Academy of Bialystok (AMB) in Poland, where he graduated in 1975. His early academic years laid a strong foundation in medical sciences, leading him to specialize in clinical and anatomical pathology. He pursued his specialization at Kings County Hospital, New York, and Downstate Medical Center, New York, between 1982 and 1985. During this period, he honed his expertise in understanding disease mechanisms and diagnostic techniques. Additionally, in 1978, he obtained his PhD in immunopharmacology from AMB, reflecting his deep interest in the interaction between the immune system and pharmacological agents. His academic credentials positioned him as a leader in integrative medicine, combining traditional knowledge with scientific advancements.

💼Professional Endeavors 

Academic Positions

Dr. Badmaev’s professional career has been defined by his dedication to bridging traditional botanical medicine with modern pharmacological science. In 1984, he established the Badmaev Natural Drug Foundation, an organization committed to exploring the therapeutic potential of natural compounds. Later, in 2009, he founded American Medical Holdings Inc. in Staten Island, New York, to advance the development of nutraceuticals and natural pharmaceutical products. Through these initiatives, he has played a crucial role in integrating the principles of traditional medicine with contemporary scientific research. His company, www.badmaevtradition.com, stands as a testament to his lifelong commitment to safe and effective alternative medicine solutions.

📚Contributions and Research Focus on Pharma

Dr. Badmaev has dedicated his career to the research and development of nutraceuticals and natural pharmaceutical products. He conceptualized the Interactive Nutrients Process (INP), a method that integrates the knowledge of botanicals with pharmacological science to develop “smart drugs” using artificial intelligence. His work has been instrumental in the advancement of various nutraceutical formulations, including C3Complex® (Sabinsa), Gugulipid® (Sabinsa), SeleniumSelect® (Sabinsa), Lactospore® (Sabinsa), Xanthigen® (PLThomas), RhodioLife® (PLThomas/Polyphenoles Naturales), Zembrin® (PLThomas/HGH), 5-Loxin®/Apres-Flex® (PLThomas), and MenaQ7® (NattoPharma). Furthermore, he has been actively involved in developing natural therapeutics such as Adaptrin®, GreenSelenium®, TurmericImmune®, SlimTrym®, and FB3® under American Medical Holdings Inc. His recent work focuses on the natural ginger phenolic derivative, 6-Shogaol, for managing iron overload and early-stage myelodysplastic syndromes (MDS). This breakthrough has resulted in a US patent, No.: US 10,864,174 B2 (2017), along with 11 related patents worldwide (2017-2024).

🏆Accolades and Recognition 

Between 1999 and 2009, Dr. Badmaev was the runner-up or recipient of four New Jersey R&D Council Thomas Alva Edison Awards. These accolades were awarded in recognition of his contributions to scientific research and patent innovations, including US patents #5,536,506, #5,804,596, #6,849,645, and #7,063,861. His extensive work in the field of nutraceutical research has earned him international recognition, leading to collaborations and multiple patent approvals in various countries, including Australia, Canada, New Zealand, Mexico, Brazil, South Africa, the European Community, Japan, Korea, India, and China.

🌍 Impact and Influence 

Community Impact

Dr. Badmaev’s influence extends beyond research and development. His contributions to literature have enriched the understanding of traditional medicine’s integration with modern healthcare. In 1999, he authored a chapter on Tibetan medicine in a medical textbook for students and healthcare professionals, edited by Wayne Jonas and Jeffrey Levine. A decade later, in 2009, he contributed to a chapter on curcuminoids in a book on alternative treatments in medicine by Raymond Cooper and Fredi Kronenberg. His scholarly work has provided valuable insights into the therapeutic applications of botanical medicine.

🔮Legacy and Future Contributions 

Dr. Badmaev’s contributions have left a lasting impact on the field of integrative medicine. His membership in esteemed medical and scientific societies, including the International Society of Immunopharmacology (1982), the American Association of Clinical Pathologists (1983), the American Medical Association (1984), and the Research and Development Council of New Jersey (1996), underscores his commitment to advancing medical science. His ongoing research into the development of AI-driven “smart drugs” signifies his vision for the future of medicine.

 

Conclusion

Vladimir Badmaev, MD, PhD, has dedicated his career to harmonizing traditional botanical medicine with scientific innovation. His pioneering research, extensive patent portfolio, and contributions to the nutraceutical industry exemplify his lifelong mission to develop safe and effective medical solutions. As he continues his work on AI-integrated nutraceuticals, his legacy serves as an inspiration for future generations in the field of integrative medicine.

📚Publications

Interactive Nutrient Process (INP) in a Generative AI of a New Drug—6-Shogaol as a Potential Case

Authors: Vladimir Badmaev

Journals: Drug Design, Development and Therapy

Vitamin K Insufficiency in the Indian Population: Pilot Observational Epidemiology Study

Authors: Rama Vaidya; Ashok D B Vaidya; Jayesh Sheth; Shashank Jadhav; Umakant Mahale; Dilip Mehta; Janusz Popko; Vladimir Badmaev; Sidney J Stohs

Journals: JMIR Public Health and Surveillance

Is 6-Shogaol an Effective Phytochemical for Patients With Lower-risk Myelodysplastic Syndrome? A Narrative Review

Authors: Soo Liang Ooi; Ron Campbell; Sok Cheon Pak; Terry Golombick; Arumugam Manoharan; Raj Ramakrishna; Vladimir Badmaev; Janet Schloss

Journals: Integrative Cancer Therapies

Proof‐of‐Concept Randomized Controlled Study of Cognition Effects of the Proprietary Extract Sceletium tortuosum (Zembrin) Targeting Phosphodiesterase‐4 in Cognitively Healthy Subjects: Implications for Alzheimer’s Dementia

Authors: Simon Chiu; Nigel Gericke; Michel Farina-Woodbury; Vladimir Badmaev; Hana Raheb; Kristen Terpstra; Joalex Antongiorgi; Yves Bureau; Zack Cernovsky; Jirui Hou et al.

Journals: Evidence-Based Complementary and Alternative Medicine

Abid Ali Fareedi | Health Informatics | Best Researcher Award

Posted on by Business Strategy

Mr. Abid Ali Fareedi – Health Informatics – Best Researcher Award

Alignment with Award Category

Given his extensive contributions to data engineering, knowledge graphs, and information architecture, Abid Ali Fareedi aligns well with awards recognizing excellence in management science and AI-driven data modeling. His work meets the high standards of innovation, academic rigor, and industry impact required for prestigious accolades in his field.

 

Halmstad University | Sweden

Profile

Scopus

🎓Early Academic Pursuits 

Education and Training

Abid Ali Fareedi began his academic journey with a strong foundation in data science and information architecture. His early education in database development at Punjab University (2005-2008) set the stage for his future endeavors. During this period, he honed his skills in analyzing business needs, designing conceptual data models, and implementing robust data strategies. His technical expertise was evident in his ability to optimize databases, oversee network labs, and perform complex backup and recovery tasks. This academic rigor paved the way for a dynamic career in data engineering and knowledge graph technologies.

💼Professional Endeavors 

Academic Positions

With an extensive career spanning multiple industries, Abid Ali Fareedi has held key positions in data architecture, project management, and semantic technologies. His work as an IT Support Analyst at 7A Sevena AB (2016-2017) showcased his ability to troubleshoot technical issues and manage critical IT infrastructure. Moving into technical project support at Bombardier Transport (2017), he contributed to engineering standardization across Europe, the US, and Asia.

📚Contributions and Research Focus on Health Informatics

Abid Ali Fareedi’s research focuses on semantic technologies, knowledge graphs, and data modeling. As an Industrial Ph.D. Consultant at LimeSense AB and Halmstad University (2020-2025), he has been at the forefront of bridging academia and industry. His work involves supervising master’s students, publishing research in peer-reviewed journals, and contributing to international conferences. His licentiate dissertation exemplifies his commitment to advancing knowledge in semantic data engineering.

🏆Accolades and Recognition 

Throughout his career, Abid Ali Fareedi has been recognized for his technical acumen and research excellence. His leadership in developing semi-automated and fully automated knowledge graphs has earned him industry-wide respect. His work in data validation (SWRL, SHACL) and federated knowledge graph strategies has been instrumental in ensuring the scalability and reliability of enterprise-level data solutions. His recognition as a reviewer for prestigious journals and conferences underscores his standing as a thought leader in his field.

🌍 Impact and Influence 

Community Impact

Abid Ali Fareedi’s impact extends beyond academia and corporate innovation. His mentorship of students and professionals in Halmstad University and LimeSense AB has shaped the next generation of knowledge graph engineers and data architects. His ability to translate business needs into scalable, semantically rich data models has redefined industry best practices. Through his work in Neo4j, GraphDB, and Cypher, he has demonstrated advanced capabilities in structuring and querying large-scale data infrastructures.

🔮Legacy and Future Contributions 

With a robust career in information architecture and knowledge graph engineering, Abid Ali Fareedi’s legacy is marked by innovation in semantic data technologies. His ongoing Ph.D. research continues to push the boundaries of AI-powered knowledge representation. Looking ahead, he aims to further enhance ontological modeling techniques, making data integration more intuitive and machine-readable across industries.

Conclusion

Abid Ali Fareedi exemplifies the fusion of academic excellence and industrial expertise. His journey from database development to leading knowledge graph innovations reflects his dedication to advancing semantic technologies. With a forward-looking approach, he continues to shape the future of AI-driven data integration, ensuring his contributions leave a lasting mark on both academia and the industry.

📚Publications

  • Next-Generation Healthcare 4.0 and Smart Homes: A Technological Framework 4.0 for Personalized Neurological Disorders Care

    Authors: A.A., Fareedi, Abid Ali

    Journals: Health Informatics

Bader Alsharif | Using Ai to protect IoMT | Best Researcher Award

Posted on by Business Strategy

Dr. Bader Alsharif   –  Using Ai to protect IoMT  –  Best Researcher Award

Research Impact

Bader’s research has the potential to revolutionize healthcare by enhancing the integration of secure AI-driven systems in medical devices and operations. His focus on cybersecurity addresses one of the most critical concerns in modern healthcare, ensuring safe and reliable use of technology. The real-world applications of his work have implications for improved healthcare delivery and operational efficiency on a global scale.

 

Florida Atlantic University  | United States

      Profile

Orcid

Scopus

Scholar

📍Current Position and Responsibilities

Bader Alsharif currently serves as a Teaching Assistant at Florida Atlantic University, a prestigious public research university in Boca Raton, United States. His role, starting in August 2023, involves guiding and mentoring over 30 students on engineering design projects. He offers technical support and fosters collaboration through office hours, assisting over 200 students with project development, design principles, and technical challenges. His dedication ensures a positive and dynamic learning environment, contributing significantly to student success.

In addition, Bader has been a Lecturer at the Communications and Information College in Riyadh, Saudi Arabia, since 2008. He played a pivotal role in managing over 300 devices, ensuring optimal performance and security. He led the installation of Saudi Arabia’s first CISCO simulation lab, which included deploying over 30 devices and routers. His exceptional contributions include designing schedules for 3,000 students and 100 instructors and supporting special-needs students, achieving a performance rating of 99/100.

 

📝Publication Achievements and Research Focus

Bader Alsharif has published over seven peer-reviewed papers in areas like Artificial Intelligence (AI), Cybersecurity, and Internet of Things (IoT). His primary research focuses on integrating these technologies to enhance healthcare solutions. This includes: Developing innovative AI-driven methods to improve patient outcomes. Exploring cybersecurity frameworks to secure sensitive healthcare data. Leveraging IoT for connected and smarter healthcare devices.

 

🔍Ongoing Research and Interests

Bader’s research interests lie at the intersection of AI, Cybersecurity, and IoT, with a specialized focus on applying these technologies to the healthcare sector. His ongoing projects aim to revolutionize patient care by integrating intelligent algorithms and secure networks. His passion for innovation is evident in his pursuit of creating sustainable, efficient, and patient-centric solutions

 

🎓Academic Background

Bader Alsharif has an impressive academic foundation: PhD in Computer Engineering (Expected May 2025) from Florida Atlantic University, USA. Master of Science in Computer Engineering (2015–2017) from Florida Institute of Technology, USA. Bachelor of Science in Computer Engineering (2003–2008) from the College of Technology, Riyadh, Saudi Arabia.

This diverse and solid academic journey reflects his commitment to advancing in the field of Computer Engineering.

 

🏆Scholarships and Awards

Bader Alsharif has consistently demonstrated excellence, receiving commendations for his achievements in teaching and research. His stellar job performance, especially his dedication to supporting individuals with special needs, has earned him outstanding ratings.

 

🌐Professional Associations  and Training 

ader actively contributes to the academic community through his association with professional organizations and certifications, including: CCNA1 certification. Certified Trainer of Trainers, enhancing his ability to mentor and train others effectively.

He has trained over 100 employees at Saudi Telecom Company, significantly boosting their technical skills through 16 well-designed courses.

 

🎤Oral Presentations and Workshops

Bader has delivered numerous presentations, simplifying complex networking concepts for students and professionals. He facilitated knowledge-sharing platforms, such as the Arab Deaf Week, showcasing the talents of over 300 participating organizations.

 

🧑‍🔬Tasks Completed as a Researcher 

Bader has successfully: Designed and implemented innovative labs, including the first CISCO simulation lab in Saudi Arabia. Developed performance assessment criteria for special-needs instructors. Published impactful research papers focusing on the convergence of AI, IoT, and Cybersecurity in healthcare.

 

🚀Success Factors 

Bader’s success is driven by: His unwavering commitment to fostering academic excellence. His ability to seamlessly integrate technical expertise with a deep understanding of healthcare challenges. His dedication to inclusivity, ensuring special-needs students excel academically.

 

🧪Publications & Laboratory Experience

Bader Alsharif’s laboratory expertise is complemented by his published works, which delve into practical solutions for real-world problems. His hands-on experience in managing devices, optimizing networks, and developing secure systems underscores his capability as a seasoned researcher.

 

💻Expertise in Bioinformatics

Bader applies his technical skills in C, Python, MATLAB, and GitHub to solve complex problems in bioinformatics. This expertise supports his ability to design, analyze, and optimize healthcare applications using advanced computational methods.

 

🔍 Conclusion

Bader Alsharif exemplifies a rare combination of academic brilliance, professional expertise, and a commitment to inclusivity. His research contributions in AI, Cybersecurity, and IoT, particularly in enhancing healthcare solutions, position him as a leader in his field. His ability to drive impactful innovations while fostering academic excellence makes him a deserving candidate for recognition and accolades. As a visionary innovator, Bader is set to make significant strides in the technological and healthcare sectors.

 

📚Publications

Enhancing Cybersecurity in Healthcare: Evaluating Ensemble Learning Models for Intrusion Detection in the Internet of Medical Things

 Author: Alsolami, T., Alsharif, B., Ilyas, M.  

 Journal: Sensors

Deep Learning Technology to Recognize American Sign Language Alphabet

Author: Alsharif, B., Altaher, A.S., Altaher, A., Ilyas, M., Alalwany, E.

Deep Learning Technology to Recognize American Sign Language Alphabet Using Mulit-Focus Image Fusion Technique

Author: Alsharif, B., Alanazi, M., Altaher, A.S., Altaher, A., Ilyas, M.

Multi-Dataset Human Activity Recognition: Leveraging Fusion for Enhanced Performance

Author: Alanazi, M., Alsharif, B., Altaher, A.S., Altaher, A., Ilyas, M.
Journal: 2023 IEEE 20th International Conference on Smart Communities: Improving Quality of Life using AI, Robotics and IoT, HONET